FRESENIUS FDA Approval ANDA 206761

ANDA 206761

FRESENIUS

FDA Drug Application

Application #206761

Application Sponsors

ANDA 206761FRESENIUS

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTIONEQ 10GM BASE/VIAL0NAFCILLIN SODIUMNAFCILLIN SODIUM

FDA Submissions

UNKNOWN; ORIG1AP2020-06-02STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

FRESENIUS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206761
            [companyName] => FRESENIUS
            [docInserts] => ["",""]
            [products] => [{"drugName":"NAFCILLIN SODIUM","activeIngredients":"NAFCILLIN SODIUM","strength":"EQ 10GM BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/02\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-06-02
        )

)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.